In-vivo assessment of normal T1 values of the right-ventricular myocardium by cardiac MRI

International Journal of Cardiovascular Imaging

Volumn 30, Issue 2, 2014, Pages 323-328

  Kawel Boehm, N ^a   Buser, T Dellas ^a   Greiser, A ^b   Bieri, O ^a   Bremerich, J ^a   Santini, F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SIEMENS AG   (Germany)

Author keywords

Diffuse fibrosis; Right ventricle; T1 mapping

Indexed keywords

ADULT; ARTICLE; ARTIFACT; BLOOD; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART RIGHT VENTRICLE; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; IMAGE RECONSTRUCTION; IN VIVO STUDY; INFORMATION PROCESSING; MALE; MEASUREMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; REPRODUCIBILITY; SHORT AXIS; SYSTOLE;

ADULT; COLLAGEN; FEASIBILITY STUDIES; FEMALE; HEALTHY VOLUNTEERS; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SYSTOLE; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 84899101240     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-013-0326-3     Document Type: Article

References (17)

1. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52(19):1574-1580. doi:10.1016/j.jacc.2008.06.049
2. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26(4):1081-1086. doi:10.1002/jmri.21119 (Pubitemid 47548170)
3. Messroghli D, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, Klein C, Berger F, Kuehne T (2011) Assessment of diffuse myocardial fibrosis in rats using small animal look-locker inversion recovery (SALLI) T1 mapping. Circ Cardiovasc Imaging. doi:10.1161/CIRCIMAGING.111.966796
4. Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, Gonzalez A, Lopez B, Diez J, Jerosch-Herold M, Kwong RY (2013) T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging. doi:10.1161/CIRCIMAGING.112.000333
5. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E (2013) Native t1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6(4):475-484. doi:10.1016/j.jcmg.2012.08.019
6. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122(2):138-144. doi:10.1161/CIRCULATIONAHA. 109.930636
7. Jellis C, Martin J, Narula J, Marwick TH (2010) Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 56(2):89-97. doi:10.1016/j.jacc.2010.02. 047
8. Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, van der Geest RJ, Bonetti C, van der Velde ET, de Roos A, Smit JW, Leung DY, Bax JJ, Lamb HJ (2012) Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging 5(1):51-59. doi:10.1161/CIRCIMAGING.111.965608
9. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M (2010) Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 3(6):727-734. doi:10.1161/CIRCIMAGING.108.842096
10. McCann GP, Gan CT, Beek AM, Niessen HW, Vonk Noordegraaf A, van Rossum AC (2007) Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol 188(2):349-355. doi:10.2214/AJR.05.1259 (Pubitemid 46167734)
11. Basso C, Corrado D, Marcus FI, Nava A, Thiene G (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373(9671):1289-1300. doi:10.1016/S0140-6736(09)60256-7
12. Plymen CM, Sado DM, Taylor AM, Bolger AP, Lambiase PD, Hughes M, Moon JC (2013) Diffuse myocardial fibrosis in the systemic right ventricle of patients late after mustard or senning surgery: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. doi:10.1093/ehjci/ jet014
13. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA (2012) T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson 14:27. doi:10.1186/1532-429X-14-27
14. Chahal H, McClelland RL, Tandri H, Jain A, Turkbey EB, Hundley WG, Barr RG, Kizer J, Lima JA, Bluemke DA, Kawut SM (2012) Obesity and right ventricular structure and function: the MESA-right ventricle study. Chest 141(2):388-395. doi:10.1378/chest.11-0172
15. Oken DE, Boucek RJ (1957) Quantitation of collagen in human myocardium. Circ Res 5(4):357-361
16. Weber KT (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13(7):1637-1652. doi:1097(89)90360-4
17. Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NA, Banerjee R, Holloway C, Hofman MB, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD (2013) Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson 15:13. doi:10.1186/1532-429X-15-13